Una guía para la práctica | 09 JUN 14

Helicobacter Pylori: ¿en quién detectar y tratar?

Análisis de la estrategia "detectar y tratar" en diversas poblaciones: úlcera, dispepsia, enfermedad por reflujo GE, prevención del cáncer gástrico.
Autor/a: Alexander C Ford, associate professor gastroenterologist, Paul Moayyedi, gastroenterology BMJ 2014; 348 doi: http://dx.doi.org/10.1136/bmj.g3320
INDICE:  1.  | 2. Referencias
Referencias
  1. NIH Consensus development panel on Helicobacter pylori in peptic ulcer disease. JAMA1994;272:65-9.CrossRefMedlineWeb of Science
  2. Ford AC, Delaney BC, Forman D, Moayyedi P. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol2004;99:1833-55.CrossRefMedlineWeb of Science
  3. Raghunath A, Hungin APS, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ2003;326:736-9.
  4. Ford AC, Forman D, Reynolds PD, Cooper BT, Moayyedi P. Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett’s esophagus. Am J Epidemiol2005;162:454-60.Abstract/FREE Full Text
  5. Yaghoobi M, Farrokhyar F, Yuan Y, Hunt RH. Is there an increased risk of GERD after Helicobacter pylori eradication?: A meta-analysis. Am J Gastroenterol2010;105:1007-13.CrossRefMedline
  6. Saad AM, Choudhary A, Bechtold ML. Effect of Helicobacter pyloritreatment on gastroesophageal reflux disease (GERD): Meta-analysis of randomized controlled trials. Scand J Gastroenterol2012;47:129-35.CrossRefMedline
  7. Xie T, Cui X, Zheng H, Chen D, He L, Jian B. Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease. Eur J Gastroenterol Hepatol2013;25:1195-205.Medline
  8. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon ATR, et al. Management of Helicobacter pylori infection—the Maastricht IV/ Florence consensus report. Gut2012;61:646-64.Abstract/FREE Full Text
  9. Moayyedi P, Forman D, Braunholtz D, Feltbower R, Crocombe W, Liptrott M, et al. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Am J Gastroenterol2000;95:1448-55.
  10. Ford AC, Qume M, Moayyedi P, Arents NLA, Lassen AT, Logan RFA, et al. Helicobacter pylori“test and treat” or endoscopy for managing dyspepsia? An individual patient data meta-analysis. Gastroenterol2005;128:1838-44.CrossRefMedlineWeb of Science
  11. Ford AC, Marwaha A, Lim A, Moayyedi P. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol2010;8:830-7.CrossRefMedline
  12. Moayyedi P. Helicobacter pylori eradication for functional dyspepsia: what are we treating? Arch Intern Med2011;171:1936-7.CrossRefMedlineWeb of Science
  13. Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, et al. Dyspepsia Review Group. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. BMJ2000;321:659-64.Abstract/FREE Full Text
  14. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et
 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022